Tirzepatide may be considered as part of a medical weight-management plan for eligible patients. Your licensed provider will review your health history and determine which treatment option, if any, is appropriate.
Tirzepatide is a GLP-1 / GIP receptor agonist studied in metabolic and weight-management research. It is given by subcutaneous injection.
A licensed provider may consider tirzepatide as one option within a medical weight-management plan, based on your health history, goals and relevant clinical factors. It is not offered as a treatment for any specific outcome.
A licensed provider reviews your intake, health history and, where appropriate, recent labs before deciding whether any treatment is suitable for you.
If a provider determines treatment is appropriate, they explain the plan, the monitoring involved and the follow-up. Care is ongoing rather than a one-time transaction.
Eligibility, dosing, side effects and alternatives are discussed with your provider. Not every patient is a candidate.
Whether any treatment is appropriate is decided by a licensed provider after an individual evaluation. Payment does not guarantee a prescription.
Start Your Assessment